Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ORIGO KLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.8% 0.8%   Bankruptcy risk   14.5% 10.3% 9.1% 16.5% 16.7% 8.6% 15.7% 15.4%   Credit score (0-100)   16 25 27 10 10 27 12 13   Credit rating   BB BB BB BB BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   549 675 828 1,136 1,168 1,100 1,100 1,100   Gross profit   169 342 382 661 561 456 0.0 0.0   EBITDA   18.2 9.2 -19.2 157 97.6 -19.5 0.0 0.0   EBIT   18.2 2.4 -26.0 139 69.5 -45.8 0.0 0.0   Pre-tax profit (PTP)   21.2 2.3 -26.2 138.3 68.1 -46.4 0.0 0.0   Net earnings   16.5 1.8 -20.4 107.8 52.8 -36.4 0.0 0.0   Pre-tax profit without non-rec. items   21.2 2.3 -26.2 138 68.1 -46.4 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 20.4 13.6 41.1 72.3 46.0 0.0 0.0   Shareholders equity total   84.1 85.9 65.5 173 133 46.6 -33.4 -33.4   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 33.4 33.4   Balance sheet total (assets)   101 132 144 283 204 113 0.0 0.0   Net Debt   -92.3 -92.5 -104 -211 -75.7 -41.8 33.4 33.4     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   549 675 828 1,136 1,168 1,100 1,100 1,100   Net sales growth   -22.0% 23.0% 22.7% 37.2% 2.8% -5.8% 0.0% 0.0%   Gross profit   169 342 382 661 561 456 0.0 0.0   Gross profit growth   -50.8% 102.3% 11.8% 72.7% -15.1% -18.7% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 -401.6 -503.2 -463.2 -475.5 0.0 0.0   Balance sheet total (assets)   101 132 144 283 204 113 0 0   Balance sheet change%   -14.0% 30.1% 9.2% 96.3% -28.0% -44.4% -100.0% 0.0%   Added value   18.2 9.2 382.4 660.6 550.9 456.0 0.0 0.0   Added value %   3.3% 1.4% 46.2% 58.1% 47.2% 41.4% 0.0% 0.0%   Investments   0 14 -14 9 3 -53 -46 0   Net sales trend   -2.0 1.0 2.0 3.0 4.0 -1.0 0.0 0.0   EBIT trend   1.0 2.0 -1.0 1.0 2.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   3.3% 1.4% -2.3% 13.9% 8.4% -1.8% 0.0% 0.0%   EBIT %   3.3% 0.4% -3.1% 12.2% 6.0% -4.2% 0.0% 0.0%   EBIT to gross profit (%)   10.8% 0.7% -6.8% 21.1% 12.4% -10.0% 0.0% 0.0%   Net Earnings %   3.0% 0.3% -2.5% 9.5% 4.5% -3.3% 0.0% 0.0%   Profit before depreciation and extraordinary items %   3.0% 1.3% -1.6% 11.1% 6.9% -0.9% 0.0% 0.0%   Pre tax profit less extraordinaries %   3.9% 0.3% -3.2% 12.2% 5.8% -4.2% 0.0% 0.0%   ROA %   19.6% 2.1% -18.8% 65.2% 28.6% -28.9% 0.0% 0.0%   ROI %   28.3% 2.9% -34.3% 116.6% 45.4% -50.9% 0.0% 0.0%   ROE %   21.7% 2.1% -27.0% 90.3% 34.4% -40.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   83.0% 65.2% 45.5% 61.3% 65.3% 41.2% -100.0% -100.0%   Relative indebtedness %   3.1% 6.8% 9.5% 9.6% 6.0% 6.0% 3.0% 3.0%   Relative net indebtedness %   -13.7% -6.9% -3.1% -9.0% -0.4% 2.2% 3.0% 3.0%   Net int. bear. debt to EBITDA, %   -506.2% -1,001.8% 545.5% -134.3% -77.5% 214.4% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   5.9 2.4 1.7 2.2 1.9 1.0 0.0 0.0   Current Ratio   5.9 2.4 1.7 2.2 1.9 1.0 0.0 0.0   Cash and cash equivalent   92.3 92.5 104.5 211.3 75.7 41.8 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   6.0 10.2 4.4 9.4 4.8 3.3 0.0 0.0   Trade creditors turnover (days)   14.4 27.9 15.0 15.3 12.1 12.2 0.0 0.0   Current assets / Net sales %   18.5% 16.5% 15.7% 21.3% 11.2% 6.1% 0.0% 0.0%   Net working capital   84.1 65.5 51.9 132.1 60.7 0.6 -16.7 -16.7   Net working capital %   15.3% 9.7% 6.3% 11.6% 5.2% 0.1% -1.5% -1.5%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0